Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Concerta 27mg modified-release tablets
0404000M0BDADAT
|
Concerta | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Concerta 54mg modified-release tablets
0404000M0BDACAR
|
Concerta | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Cyclimorph 15 solution for injection 1ml ampoules
040702020BBABAB
|
Cyclimorph | Morphine tartrate and cyclizine tartrate | Central Nervous System | No data available |
|
Cyclizine 10mg/5ml oral liquid
0406000F0AABABA
|
Cyclizine hydrochloride | Cyclizine hydrochloride | Central Nervous System | No data available |
|
Cyclizine 12.5mg suppositories
0406000F0AAATAT
|
Cyclizine hydrochloride | Cyclizine hydrochloride | Central Nervous System | No data available |
|
Cyclizine 12.5mg/5ml oral liquid
0406000F0AAASAS
|
Cyclizine hydrochloride | Cyclizine hydrochloride | Central Nervous System | No data available |
|
Cyclizine 2.5mg/5ml oral liquid
0406000F0AABCBC
|
Cyclizine hydrochloride | Cyclizine hydrochloride | Central Nervous System | No data available |
|
Cyclizine 250mg/5ml oral liquid
0406000F0AAAXAX
|
Cyclizine hydrochloride | Cyclizine hydrochloride | Central Nervous System | No data available |
|
Cyclizine 25mg/5ml oral liquid
0406000F0AAAVAV
|
Cyclizine hydrochloride | Cyclizine hydrochloride | Central Nervous System | No data available |
|
Cyclizine 30mg/5ml oral liquid
0406000F0AAAZAZ
|
Cyclizine hydrochloride | Cyclizine hydrochloride | Central Nervous System | No data available |
|
Cyclizine 62.5mg/5ml oral liquid
0406000F0AAAUAU
|
Cyclizine hydrochloride | Cyclizine hydrochloride | Central Nervous System | No data available |
|
Cynril 1.2mg lozenges with integral oromucosal applicator
0407020A0BWAEAN
|
Cynril | Fentanyl | Central Nervous System | No data available |
|
Dalmane 15mg capsules
0401010L0BBAAAA
|
Dalmane | Flurazepam hydrochloride | Central Nervous System | No data available |
|
Dalmane 30mg capsules
0401010L0BBABAB
|
Dalmane | Flurazepam hydrochloride | Central Nervous System | No data available |
|
Day & Night Nurse capsules
0407010X0CWAAA0
|
Day & Night Nurse | Paracetamol combined preparations | Central Nervous System | No data available |
|
Day Nurse capsules
0407010X0CLABA0
|
Day Nurse | Paracetamol combined preparations | Central Nervous System | No data available |
|
Day Nurse oral solution
0407010X0CLAAA0
|
Day Nurse | Paracetamol combined preparations | Central Nervous System | No data available |
|
Defanyl 100mg tablets
0403010C0BCAAAC
|
Defanyl | Amoxapine | Central Nervous System | No data available |
|
Demorem 4mg/5ml oral solution
0406000S0BDAAAG
|
Demorem | Ondansetron hydrochloride | Central Nervous System | No data available |
|
Dental Pain Relief tablets
0407010N0BEABAJ
|
Boots (co-dydramol) | Co-dydramol (Dihydrocodeine/paracetamol) | Central Nervous System | No data available |
|
Denzapine 200mg tablets
0402010C0BCADAD
|
Denzapine | Clozapine | Central Nervous System | No data available |
|
Denzapine 50mg/ml oral suspension
0402010C0BCAEAE
|
Denzapine | Clozapine | Central Nervous System | No data available |
|
Depakote 125mg sprinkle gastro-resistant capsules
040801020BCACAH
|
Depakote (Epilepsy) | Valproic acid | Central Nervous System | No data available |
|
Deseril 1mg tablets
0407042L0BBAAAA
|
Deseril | Methysergide | Central Nervous System | No data available |
|
Dexamfetamine 100mg/5ml oral liquid
0404000L0AAAQAQ
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.